LAMP2 / Lysosome-associated membrane glycoprotein 2 · Western blot design guide

Design a Western Blot for LAMP2

Real validated LAMP2 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-LAMP2 WB antibodies. Everything you need to plan the experiment before you commit precious samples.

Evidence assembled September 2026 · For research use; verify linked source records and product datasheet before use
Western blot protocol sheet for LAMP2: expected band ~45 kDa, hero antibody A01573, catalog values and labelled standard workflow; separate PMC comparisons on the guide
Printable LAMP2 Western blot protocol sheet — expected band ~45 kDa, antibody A01573, controls and PMC citations. Open the full LAMP2 WB guide →

LAMP2 Western Blot Experimental Design Guide

Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band ~45 kDa
Gel 12–15% (standard starting point)
Positive control ⓘ Cerebellum (IHC candidate; verify WB) +4 more
Negative control ⓘ Suggested KO / knockdown lysate
Important caveats
Reasons your observed band may differ from the expected size.
PTM Glycosylated + Cleaved
Caveat Glycosylation-state controls
Gene-set association MSigDB Hallmark membership
Isoform 3 isoform(s)
Section 1

Real Curated LAMP2 Western Blot Protocols

The A01573 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.

Recommended Western blot protocol parameters
Sample / lysateHepG2 cell lysate (catalog A01573)
Gel %12–15% (standard starting point)
Load20–30 µg total protein per lane; optimize for abundance (standard starting point)
TransferStandard semi-dry transfer; verify efficiency (standard starting point)
Membrane0.45 µm PVDF (standard starting point)
Blocking5% milk or 5% BSA in TBST (standard starting point)
Primary antibodyA01573 · (A) 1 and (B) 2 μg/mL (catalog A01573)
Primary incubationOvernight at 4 °C (standard starting point)
Secondary antibodySpecies-matched HRP conjugate at validated dilution (standard starting point)
Secondary incubation1 h at room temperature (standard starting point)
Wash3 × 5 min in TBST (standard starting point)
DetectionECL; bracket exposures to avoid saturation (standard starting point)
Section 2

What Is the Expected LAMP2 Western Blot Band Size?

UniProt predicts a 45 kDa LAMP2 precursor; glycosylation, signal-peptide removal, isoforms and oligomers may affect bands, but no empirical migration is supplied.

What am I looking at on my blot?
Band near 45 kDaConsistent with the predicted precursor mass; identity needs confirmation.
Band above 45 kDaMay reflect N-linked glycosylation; its migration is not established.
Band below 45 kDaMay reflect removal of the signal peptide at residues 1–28.
Additional bands at different positionsCould reflect LAMP-2A, LAMP-2B and LAMP-2C; distinct migration is not established.
Band near twice the monomer positionCould reflect a homodimer if it persists during electrophoresis.
💡Expected LAMP2 appearanceUniProt predicts a 45 kDa precursor; no empirical band size is supplied, and glycosylation, signal-peptide cleavage and isoforms warrant checking band identity with appropriate controls.
How each factor affects band size
UniProt predicted precursor massSets a 45 kDa sequence-based reference, not a validated migration position.
N-linked glycosylation at Asn-32 and Asn-38May raise apparent mass; both sites carry polylactosaminoglycan annotations.
Signal peptide at residues 1–28Its removal makes the mature chain smaller than the precursor.
LAMP-2A, LAMP-2B and LAMP-2C isoformsMay differ in size; their individual masses and migration are not supplied.
Homodimer formationMay yield a band near twice the monomer position if the complex survives electrophoresis.
Why is my band missing or off?
SituationLikely causeNext action
No band in lysateLAMP2 is a lysosome and endosome membrane protein that may be poorly recovered.Check membrane protein extraction and compare a membrane-enriched fraction.
Band higher than expectedN-linked glycans or persistent homooligomers may increase apparent size.Compare reducing conditions and assess glycosylation with appropriate controls.
Band lower than expectedRemoval of the residues 1–28 signal peptide reduces chain size.Check antibody epitope coverage and confirm band identity with an independent antibody.
Broad smear instead of sharp bandHeterogeneous N-linked glycosylation is possible across the annotated sites.Compare glycosidase-treated and untreated samples with a loading control.
Multiple bandsThe three named isoforms or persistent oligomers may contribute, but distinct bands are unproven.Compare reducing conditions and validate bands with an independent antibody.
Weak or no signalExtraction may recover little membrane-associated LAMP2.Check transfer and loading, then compare membrane-enriched lysate.

Sample controls for LAMP2 Western blot

🧪HPA-IHC candidate guidance (verify in WB): For positive controls for LAMP2 in Western blot, you can use cerebellum tissue lysate.
Positive control: Cerebellum (IHC candidate; verify WB)
Negative control: Suggested KO / knockdown lysate
Loading controls: Run GAPDH, β-actin, and a total-protein stain alongside the samples.
⚠️Feasibility: No tissue is reported as undetected, so use siRNA knockdown or a KO line for a clean negative control.

HPA tissue expression evidence for LAMP2

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Higher expression tissues · candidate positive controls from IHC

TissueCell typeLevelEvidenceSource
Cerebellum Bergmann glia - cytoplasm/membrane High Protein (IHC) HPA →
Epididymis glandular cells High Protein (IHC) HPA →
Gallbladder glandular cells High Protein (IHC) HPA →
Kidney proximal tubules (cell body) High Protein (IHC) HPA →
Placenta trophoblastic cells High Protein (IHC) HPA →

Lower expression tissues · IHC evidence, not confirmed WB-negative controls

TissueCell typeLevelEvidenceSource
Heart muscle cardiomyocytes Low Protein (IHC) HPA →
Skeletal muscle myocytes Low Protein (IHC) HPA →
Smooth muscle smooth muscle cells Low Protein (IHC) HPA →
Adipose tissue adipocytes Medium Protein (IHC) HPA →
Adrenal gland glandular cells Medium Protein (IHC) HPA →
Section 3

Advanced LAMP2 Western Blot Tips

Deeper troubleshooting and optimisation questions for LAMP2, answered from its protein features.

How should LAMP2 band migration be interpreted?
Band shift · Use the separately labelled calculated mass and catalog-observed evidence above. A sequence annotation does not establish an observed migration shift. Verify target identity with orthogonal controls.
Could LAMP2 isoforms affect antibody recognition?
Isoforms · LAMP-2A, LAMP-2B and LAMP-2C are listed. LAMP-2B replaces residues 367–410 and LAMP-2C replaces residues 366–410 in UniProt coordinates. Check whether the antibody epitope lies in these differing regions before comparing isoform signals.
Which LAMP2 glycosylation features matter when interpreting band patterns?
PTM · UniProt lists N-linked sites, including polylactosaminoglycan annotations at residues 32, 38 and 307, plus O-linked sites at residues 195–213. O-linked sites 207, 209 and 213 are annotated as partial. These are UniProt sequence coordinates. The annotations do not establish which sites are occupied in your sample or whether they cause a visible shift.
Does this guide establish induction of LAMP2?
Induction · No general induction response is established by this guide. A pathway or gene-set association is not evidence of induction in a particular specimen. Verify the relevant treatment and control in a target-specific experiment.
How should transfer be checked for LAMP2?
Transfer · Standard workflow guidance: verify transfer efficiency for the intended target size before interpreting a weak signal. Use total-protein assessment and optimize transfer for the membrane, gel and apparatus; the labelled catalog values take precedence.
How should blocking be optimized?
Blocking · Standard workflow guidance: follow the A01573 datasheet where specified. Otherwise compare 5% milk or 5% BSA in TBST; for a phospho-specific assay start with BSA. Optimize background and specific signal with matched controls.
How should LAMP2 bands be quantified across samples?
Quantitation · Use a consistent band selection and normalization approach across samples. LAMP2 has three isoforms and 26 annotated glycosylation sites, so confirm that the antibody recognizes the forms you intend to compare. The supplied record gives no empirical band position for defining an integration region.
Why might LAMP2 migrate differently from its predicted 45 kDa mass?
Interpretation · The 45 kDa value is a predicted mass. UniProt lists 26 glycosylation sites and a signal peptide at residues 1–28, both relevant when interpreting migration. These features alone cannot establish an apparent band size or explain a specific difference; no observed band was supplied.

UniProt annotates a signal peptide at residues 1–28. If an antibody targets this region, check whether its epitope is present in the processed protein. Use UniProt sequence coordinates when comparing antibody and feature annotations.

UniProt reports LAMP2 as a monomer, homodimer, homotrimer and member of larger homooligomers. These associations make oligomers a possibility to investigate, but the feature record does not show that any particular Western-blot band is an oligomer. Compare bands under your sample preparation conditions before assigning them.

Check antibody epitope coverage of the isoform-specific regions at residues 366–410, consider the annotated glycosylation sites, and compare with the 1–28 signal peptide annotation. UniProt also reports oligomers. None of these features alone identifies an observed band, and no empirical band size was supplied.
Boster reagents

LAMP2 Western Blot Antibodies

Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.

Real WB data Western blot analysis of LAMP-2 in HepG2 cell lysate with LAMP-2 antibody at (A) 1 and (B) 2 μg/mL.
Anti-LAMP-2 Antibody
Cat # A01573
Real WB data Western blot analysis of LAMP2 expression in JAR cell lysate.
Anti-LAMP2a Rabbit Monoclonal Antibody
Cat # M01573
Real WB data Western blot analysis of LAMP2 using anti-LAMP2 antibody (A01573-3). Electrophoresis was performed on a 5-20% SDS-PAGE gel at 70V (Stacking gel) / 90V (Resolving gel) for 2-3 hours. The sample well of each lane was loaded with 30 ug of sample under reducing conditions. Lane 1: human U-87MG whole cell lysates, Lane 2: human PC-3 whole cell lysates, Lane 3: human 293T whole cell lysates, Lane 4: human Jurkat whole cell lysates, Lane 5: human HepG2 whole cell lysates, Lane 6: human Hela whole cell lysates. After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-LAMP2 antigen affinity purified polyclonal antibody (Catalog # A01573-3) at 0.5 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for LAMP2 at approximately 100-110 kDa. The expected band size for LAMP2 is at 45 kDa.
Anti-LAMP2 Antibody Picoband®
Cat # A01573-3

Three the supplier anti-LAMP2 antibodies have WB images: A01573 in HepG2 lysate, M01573 in JAR lysate, and A01573-3 in six human cell lysates. No publication evidence is supplied. A01573-3 reports a 100–110 kDa band versus an expected 45 kDa.

Which to pick: Choose by listed reactivity: A01573 covers human and mouse, M01573 covers human, mouse and rat, and A01573-3 covers human. All have WB images. For human samples, A01573-3 provides detailed conditions, but note its reported band-size discrepancy.

Source: BosterBio LAMP2 gene-info card — filtered to Western-blot-capable antibodies; each card shows that product's actual WB validation figure.